Atlas Trials

A Trial of HR091506 Tablets in Treatment of Primary Gout With Hyperuricemia in Adults

Clinical trial NCT05347498 · UNKNOWN

Trial details

NCT number
NCT05347498
Sponsor
Jiangsu HengRui Medicine Co., Ltd.
Status
UNKNOWN
Phase
Phase 1
Study type
INTERVENTIONAL
Primary Gout With Hyperuricemia in Adults
Start date
2022-04-30
Primary completion
2022-07-31
Enrollment
90

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.